Similar radiation sensitivities of acutely and chronically hypoxic cells in HT 1080 fibrosarcoma xenografts

Radiation Research

Volumn 159, Issue 1, 2003, Pages 94-101

  Vordermark, Dirk ^a   Menke, Douglas R ^a   Brown, J Martin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

AEROBIC CELL CULTURE; ARTICLE; CELL HYPOXIA; CELL SURVIVAL; CELL VIABILITY; CLONOGENESIS; COLONY FORMING UNIT; CONTROLLED STUDY; EXPRESSION VECTOR; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; REOXYGENATION; XENOGRAFT;

EID: 0037227501     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2003)159[0094:SRSOAA]2.0.CO;2     Document Type: Article

References (25)

1. E. K. Rofstad, K. Sundfor, H. Lyng and C. G. Trope, Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. Br. J. Cancer 83, 354-359 (2000).
2. D. M. Brizel, G. S. Sibley, L. R. Prosnitz, R. L. Scher and M. W. Dewhirst, Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 38, 285-289 (1997).
3. M. J. Trotter, D. J. Chaplin and P. L. Olive, Use of a carbocyanine dye as a marker of functional vasculature in murine tumours. Br. J. Cancer 59, 706-709 (1989).
4. D. J. Chaplin, P. L. Olive and R. E. Durand, Intermittent blood flow in a murine tumor: Radiobiological effects. Cancer Res. 47, 597-601 (1987).
5. J. M. Brown, Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br. J. Radiol. 52, 650-656 (1979).
6. J. A. Raleigh, S. C. Chou, G. E. Arteel and M. R. Horsman, Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat. Res. 151, 580-589 (1999).
7. R. J. Hodgkiss, L. Webster and G. D. Wilson, Development of bioreductive markers for tumour hypoxia. Acta Oncol. 34, 351-355 (1995).
8. S. M. Evans, W. T. Jenkins, B. Joiner, E. M. Lord and C. J. Koch, 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. Cancer Res. 56, 405-411 (1996).
9. E. K. Rofstad and K. Maseide, Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: Acute and chronic hypoxia in individual tumours. Int. J. Radiat. Biol. 75, 1377-1393 (1999).
10. K. Haustermans, I. Hofland, L. Van de Pavert, K. Geboes, M. Varia, J. Raleigh and A. C. Begg, Diffusion limited hypoxia estimated by vascular image analysis: Comparison with pimonidazole staining in human tumors. Radiother. Oncol. 55, 325-333 (2000).
11. J. Bernier, J. Denekamp, A. Rojas, E. Minatel, J. Horiot, H. Hamers, P. Antognoni, O. Dahl, P. Richaud and M. Pierart, ARCON: Accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the co-operative group of radiotherapy of the European organization for research and treatment of cancer (EORTC). Radiother. Oncol. 55, 111-119 (2000).
12. J. H. Kaanders, L. A. Pop, H. A. Marres, J. Liefers, F. J. van den Hoogen, W. A. van Daal and A. J. van der Kogel, Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer. Radiother. Oncol. 48, 115-122 (1998).
13. J. Denekamp and A. Dasu, Inducible repair and the two forms of tumour hypoxia - time for a paradigm shift. Acta Oncol. 38, 903-918 (1999).
14. M. C. Joiner, B. Marples, P. Lambin, S. C. Short and I. Turesson, Low-dose hypersensitivity: Current status and possible mechanisms. Int. J. Radiat. Oncol. Biol. Phys. 49, 379-389 (2001).
15. T. Danielsen, R. Skoyum and E. K. Rofstad, Hypoxia-induced changes in radiation sensitivity in human melanoma cells: Importance of oxygen-regulated proteins, adenylate energy charge and cell cycle distribution. Radiother. Oncol. 44, 177-182 (1997).
16. P. Birner, M. Schindl, A. Obermair, C. Plank, G. Breitenecker and G. Oberhuber, Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 60, 4693-4696 (2000).
17. D. M. Aebersold, P. Burri, K. T. Beer, J. Laissue, V. Djonov, R. H. Greiner and G. L. Semenza, Expression of hypoxia-inducible factor-1α. A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 61, 2911-2916 (2001).
18. J. A. Loncaster, A. L. Harris, S. E. Davidson, J. P. Logue, R. D. Hunter, C. C. Wycoff, J. Pastorek, P. J. Ratcliffe, I. J. Stratford and C. M. West, Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 61, 6394-6399 (2001).
19. D. Vordermark, T. Shibata and J. M. Brown, Green fluorescent protein is a suitable reporter of tumor hypoxia despite an oxygen requirement for chromophore formation. Neoplasia 3, 527-534 (2001).
20. T. Shibata, A. J. Giaccia and J. M. Brown, Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther. 7, 493-498 (2000).
21. M. S. Kovacs, D. J. Hocking, J. W. Evans, B. G. Siim, B. G. Wouters and J. M. Brown, Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin. Br. J. Cancer 80, 1245-1251 (1999).
22. P. L. Olive, R. E. Durand, J. A. Raleigh, C. Luo and C. Aquino-Parsons, Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia. Br. J. Cancer 83, 1525-1531 (2000).
23. P. L. Olive, C. Aquino-Parsons, S. H. MacPhail, S. Y. Liao, J. A. Raleigh, M. I. Lerman and E. J. Stanbridge, Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res. 61, 8924-8929 (2001).
24. E. M. Buffa, C. West, K. Byrne, J. V. Moore and A. E. Nahum, Radiation response and cure rate of human colon adenocarcinoma spheroids of different size: The significance of hypoxia on tumor control modelling. Int. J. Radiat. Oncol. Biol. Phys. 49, 1109-1118 (2001).
25. B. G. Wouters and J. M. Brown, Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. Radiat. Res. 147, 541-550 (1997).